Literature DB >> 25480565

The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.

Philippa M Saunders1, Julian P Vivian2,3, Nikola Baschuk4, Travis Beddoe2, Jacqueline Widjaja1, Geraldine M O'Connor5, Corinne Hitchen2, Phillip Pymm2, Daniel M Andrews4, Stephanie Gras2, Daniel W McVicar5, Jamie Rossjohn2,6,3, Andrew G Brooks1.   

Abstract

The killer cell Ig-like receptor 3DL1 (KIR3DL1) inhibits activation of NK cells upon interaction with HLA class I molecules such as HLA-B*57:01, which contains the Bw4 epitope spanning residues 77-83 (e.g., NLRIALR), and not with HLA allomorphs that possess the Bw6 motif (e.g., HLA-B*08:01), which differ at residues 77, 80, 81, 82, and 83. Although Bw4 residues Ile(80) and Arg(83) directly interact with KIR3DL1*001, their precise role in determining KIR3DL1-HLA-Bw4 specificity remains unclear. Recognition of HLA-B*57:01 by either KIR3DL1(+) NK cells or the NK cell line YTS transfected with KIR3DL1*001 was impaired by mutation of residues 80 and 83 of HLA-B*57:01 to the corresponding amino acids within the Bw6 motif. Conversely, the simultaneous introduction of three Bw4 residues at positions 80, 82, and 83 into HLA-B*08:01 conferred an interaction with KIR3DL1*001. Structural analysis of HLA-B*57:01, HLA-B*08:01, and mutants of each bearing substitutions at positions 80 and 83 revealed that Ile(80) and Arg(83) within the Bw4 motif constrain the conformation of Glu(76), primarily through a salt bridge between Arg(83) and Glu(76). This salt bridge was absent in HLA-Bw6 molecules as well as position 83 mutants of HLA-B*57:01. Mutation of the Bw4 residue Ile(80) also disrupted this salt bridge, providing further insight into the role that position 80 plays in mediating KIR3DL1 recognition. Thus, the strict conformation of HLA-Bw4 allotypes, held in place by the Glu(76)-Arg(83) interaction, facilitates KIR3DL1 binding, whereas Bw6 allotypes present a platform on the α1 helix that is less permissive for KIR3DL1 binding.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480565      PMCID: PMC4282956          DOI: 10.4049/jimmunol.1402542

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Andrew G Brooks; Anthony W Purcell; Marcos R Fontes; James McCluskey; Jamie Rossjohn
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

2.  Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.

Authors:  Geraldine M O'Connor; Kieran J Guinan; Rodat T Cunningham; Derek Middleton; Peter Parham; Clair M Gardiner
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 3.  A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned.

Authors:  Stephanie Gras; Scott R Burrows; Stephen J Turner; Andrew K Sewell; James McCluskey; Jamie Rossjohn
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

4.  CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells.

Authors:  Xi Chen; David S J Allan; Konrad Krzewski; Baoxue Ge; Hernan Kopcow; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

5.  Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules.

Authors:  Lena Fadda; Geraldine M O'Connor; Swati Kumar; Alicja Piechocka-Trocha; Clair M Gardiner; Mary Carrington; Daniel W McVicar; Marcus Altfeld
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

6.  Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.

Authors:  Geraldine M O'Connor; Julian P Vivian; Jacqueline M Widjaja; John S Bridgeman; Emma Gostick; Bernard A P Lafont; Stephen K Anderson; David A Price; Andrew G Brooks; Jamie Rossjohn; Daniel W McVicar
Journal:  J Immunol       Date:  2014-02-21       Impact factor: 5.422

7.  Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.

Authors:  Diana Chessman; Lyudmila Kostenko; Tessa Lethborg; Anthony W Purcell; Nicholas A Williamson; Zhenjun Chen; Lars Kjer-Nielsen; Nicole A Mifsud; Brian D Tait; Rhonda Holdsworth; Coral Ann Almeida; David Nolan; Whitney A Macdonald; Julia K Archbold; Anthony D Kellerher; Debbie Marriott; Simon Mallal; Mandvi Bharadwaj; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

8.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

9.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.

Authors:  O Mandelboim; H T Reyburn; M Valés-Gómez; L Pazmany; M Colonna; G Borsellino; J L Strominger
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  14 in total

1.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

2.  The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.

Authors:  Shoeib Moradi; Richard Berry; Phillip Pymm; Corinne Hitchen; Simone A Beckham; Matthew C J Wilce; Nicholas G Walpole; Craig S Clements; Hugh H Reid; Matthew A Perugini; Andrew G Brooks; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

3.  The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function.

Authors:  Philippa M Saunders; Bruce J MacLachlan; Phillip Pymm; Patricia T Illing; Yuanchen Deng; Shu Cheng Wong; Clare V L Oates; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian; Andrew G Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-13       Impact factor: 11.205

4.  Association of KIR Genes and MHC Class I Ligands with Atopic Dermatitis.

Authors:  David J Margolis; Nandita Mitra; Ole J Hoffstad; Brian S Kim; Dimitri S Monos; Elizabeth J Phillips
Journal:  J Immunol       Date:  2021-08-18       Impact factor: 5.426

5.  HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study.

Authors:  David J Margolis; Nandita Mitra; Brian S Kim; Jamie L Duke; Ron A Berna; Ole J Hoffstad; Jenna R Wasserman; Deborah A Ferriola; Tim L Mosbruger; Bradley S Wubbenhorst; Kathrine L Nathanson; Dimitri S Monos
Journal:  J Immunol       Date:  2021-04-16       Impact factor: 5.422

6.  Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.

Authors:  Geraldine M O'Connor; Julian P Vivian; Emma Gostick; Phillip Pymm; Bernard A P Lafont; David A Price; Jamie Rossjohn; Andrew G Brooks; Daniel W McVicar
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

7.  Can Selective MHC Downregulation Explain the Specificity and Genetic Diversity of NK Cell Receptors?

Authors:  Paola Carrillo-Bustamante; Can Kesmir; Rob J de Boer
Journal:  Front Immunol       Date:  2015-06-16       Impact factor: 7.561

Review 8.  The evolution of natural killer cell receptors.

Authors:  Paola Carrillo-Bustamante; Can Keşmir; Rob J de Boer
Journal:  Immunogenetics       Date:  2015-09-21       Impact factor: 2.846

9.  Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.

Authors:  Philippa M Saunders; Phillip Pymm; Gabriella Pietra; Victoria A Hughes; Corinne Hitchen; Geraldine M O'Connor; Fabrizio Loiacono; Jacqueline Widjaja; David A Price; Michela Falco; Maria Cristina Mingari; Lorenzo Moretta; Daniel W McVicar; Jamie Rossjohn; Andrew G Brooks; Julian P Vivian
Journal:  J Exp Med       Date:  2016-04-04       Impact factor: 14.307

10.  Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.

Authors:  George Van Den Driessche; Denis Fourches
Journal:  J Cheminform       Date:  2018-01-30       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.